Is there a suitable way to purchase genuine larotrectinib

Introduction: In the wave of medical progress, Larotrectinib, as a breakthrough broad-spectrum anti-cancer drug, lights up the light of hope for cancer patients carrying NTRK gene fusions. Since its successful launch in China, countless patients and families have placed high hopes on it and are looking forward to regaining their health through this innovative treatment. However, although larotrectinib has shown excellent therapeutic potential, its high price has not yet been included in the Chinese medical insurance system, causing some patients to face heavy financial pressure.

Domestic purchase methods

Regular hospital pharmacies: Patients should first consider purchasing at a large hospital pharmacy with tumor treatment qualifications. These hospitals usually cooperate with regular drug suppliers, which can ensure the quality and source of drugs, while providing professional medication guidance and follow-up services.

Designated pharmacies: Some pharmacies are authorized to sell certain high-value anticancer drugs, including larotrectinib. Patients can go to these designated pharmacies to purchase through hospital recommendations or self-inquiry. When purchasing, be sure to bring a prescription from your doctor and check the drug information carefully.

Cross-border medical consultation: For patients with limited domestic purchasing channels or high prices, you may consider using cross-border medical consulting agencies to learn about foreign purchasing channels. However, it should be noted that cross-border drug purchases must strictly abide by relevant laws and regulations to ensure the authenticity and safety of the drugs.

Overview of adverse reactions of larotrectinib

Larotrectinib may cause a series of adverse reactions during treatment, the most common of which have an incidence rate of more than 20% and include the following categories:

Abnormal liver function: mainly manifested as an increase in aspartate aminotransferase (AST) and alanine aminotransferase (ALT), indicating that the liver may be affected by the drug. Patients need to regularly monitor liver function during the initial and subsequent stages of treatment to facilitate timely detection and treatment.

Hematological abnormalities: including anemia, neutropenia, leukopenia, lymphopenia, etc. These reactions may affect the patient's immune function and hematopoietic system. The doctor will adjust the dosage or take other treatment measures according to the patient's specific condition.

Systemic symptoms and digestive system reactions: Patients may have systemic symptoms such as fatigue, musculoskeletal pain, and hypoalbuminemia, as well as digestive system reactions such as constipation, diarrhea, nausea, vomiting, and abdominal pain. These adverse reactions may affect the patient's daily quality of life and treatment compliance, and doctors need to be informed in time and take corresponding measures to alleviate them.